The Nio Lineup Now Consists of 3 Instruments: the accessible Nio™ E configuration provides the essence of Crystal Digital™ PCR to all labs, the Nio™ is a flexible mid-level instrument and the Nio™+ remains the flagship of the Nio family.
Vertex shares up after full-year product revenue guidance boost – Pharmaceutical Technology
Shares in Vertex rose following the lifted guidance for 2024. Image credit: Shutterstock / JHVEPhoto. Vertex Pharmaceuticals has seen a 12% revenue uptick in Q3